Drive to get people to participate in Johnson & Johnson coronavirus vaccine trial kicks off at N.J. hospital
Updated Dec 30, 2020;
Posted Dec 29, 2020
Drug trial participant receives an injection from Abimbola Coker, RN. Janssen Pharmaceutical Companies of Johnson & Johnson’s Phase 3 COVID-19 vaccine trial named ENSEMBLE 2, at the Jersey Shore University Medical Center. in Neptune, N.J. December, 29, 2020
Yellow tape is placed on the syringe so participants cannot tell if they receive the drug or the placebo.
Ed Murray | NJ Advance Media for
Facebook Share
A recruitment drive to enroll participants for Johnson & Johnson’s coronavirus virus vaccine trial kicked off Tuesday at Jersey Shore University Medical Center as the New Jersey-based company seeks to give the public another vaccination option.
Quest Diagnostics Incorporated logo. (PRNewsFoto/Quest Diagnostics Incorporated)
SECAUCUS, N.J. and NUTLEY, N.J., Dec. 22, 2020 /PRNewswire/ Hackensack Meridian
Health (HMH), the largest, most comprehensive and truly integrated health care network in New Jersey, and Quest Diagnostics (NYSE: DGX), the world s leading provider of diagnostic information services, are teaming up to enhance the quality and value of diagnostic services to patients and their doctors.
Quest Diagnostics will manage laboratory operations and perform reference testing for 11 Hackensack Meridian Health hospitals under the long-term full laboratory management agreement. Financial terms of the arrangement were not disclosed. Our partnership with Quest helps Hackensack Meridian Health continue to live our mission which is to transform health care in New Jersey and beyond, said Robert C. Garrett, CEO of Hackensack Meridian
CBS News
Health care workers feel spark of hope as U.S. poised to approve second COVID vaccine
Last Updated Dec 16, 2020 5:47 PM EST
The U.S. is possibly days away from having two authorized COVID-19 vaccines after the Food and Drug Administration s review of the Moderna vaccine signaled a strong endorsement. The news comes as the Pfizer vaccine, which rolled out Monday, is being administered in places like New York s Mt. Sinai hospital, which just seven to eight months ago, was overwhelmed with coronavirus patients.
The FDA on Tuesday said the Moderna vaccine is 86.4% effective in people 65 and over. Like the Pfizer vaccine, it s given in two doses. But Moderna s doses can be stored at normal refrigerator temperatures for 30 days. Six million doses could go out as soon as the FDA gives the green light.